amplification
The firm obtained FDA breakthrough device designation in 2019 for its protein misfolding cyclic amplification technology and SynTap assay.
Bionano Genomics, NuProbe Global Collaborate on Reproductive Health, Cancer Liquid Biopsies
The firms will integrate NuProbe's quantitative amplicon sequencing and blocker displacement amplification technologies with Bionano's Saphyr optical genome mapping platform.
Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform
Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.
Helix Gets FDA Emergency Use Authorization for NGS-Based COVID-19 Test
The in vitro diagnostic test runs on the Illumina NovaSeq 6000 instrument and will be performed at Helix's San Diego CLIA-certified laboratory.
Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity
FBB Biomed, cofounded by a diagnostics industry veteran, is attempting to develop a blood RNA test to predict COVID-19 disease severity.
May 16, 2018